39 related articles for article (PubMed ID: 9343946)
1. Neural-specific alterations in glycosphingolipid biosynthesis and cell signaling associated with two human ganglioside GM3 synthase deficiency variants.
Dookwah M; Wagner SK; Ishihara M; Yu SH; Ulrichs H; Kulik MJ; Zeltner N; Dalton S; Strauss KA; Aoki K; Steet R; Tiemeyer M
Hum Mol Genet; 2023 Dec; 32(24):3323-3341. PubMed ID: 37676252
[TBL] [Abstract][Full Text] [Related]
2. Current state-of-the-art on ganglioside-mediated immune modulation in the tumor microenvironment.
van der Haar Àvila I; Windhouwer B; van Vliet SJ
Cancer Metastasis Rev; 2023 Sep; 42(3):941-958. PubMed ID: 37266839
[TBL] [Abstract][Full Text] [Related]
3. N -butyldeoxynojirimycin reduces growth and ganglioside content of experimental mouse brain tumours.
Ranes MK; El-Abbadi M; Manfredi MG; Mukherjee P; Platt FM; Seyfried TN
Br J Cancer; 2001 Apr; 84(8):1107-14. PubMed ID: 11308262
[TBL] [Abstract][Full Text] [Related]
4. Changes in ganglioside contents, plasma sialic acid and cAMP levels in experimental hepatoma in mice.
Lu CQ; Lu J; Wang BL; Cui YZ
Mol Cell Biochem; 2000 Apr; 207(1-2):29-33. PubMed ID: 10888223
[TBL] [Abstract][Full Text] [Related]
5. Glycosyltransferase activities in human meningiomas. Preliminary results.
Gornati R; Basu S; Montorfano G; Berra B
Cancer Biochem Biophys; 1995 Jun; 15(1):1-10. PubMed ID: 8536214
[TBL] [Abstract][Full Text] [Related]
6. Changes in glycosphingolipid composition during differentiation of human leukemic granulocytes in chronic myelogenous leukemia compared with in vitro granulocytic differentiation of human promyelocytic leukemia cell line HL-60.
Nojiri H; Takaku F; Ohta M; Miura Y; Saito M
Cancer Res; 1985 Dec; 45(12 Pt 1):6100-6. PubMed ID: 3864527
[TBL] [Abstract][Full Text] [Related]
7. Oncogene transgenic mice: an useful model to study in vivo the relationships between gangliosides and oncogenes.
Colombo I; Monteggia E; Moretti S; Mangiarini L; Sacco MG; Villa A; Rapelli S; Clerici L; Berra B
Cancer Biochem Biophys; 1998 Oct; 16(3):229-42. PubMed ID: 10072207
[TBL] [Abstract][Full Text] [Related]
8. Ganglioside depletion and EGF responses of human GM3 synthase-deficient fibroblasts.
Liu Y; Su Y; Wiznitzer M; Epifano O; Ladisch S
Glycobiology; 2008 Aug; 18(8):593-601. PubMed ID: 18480157
[TBL] [Abstract][Full Text] [Related]
9. Developmental changes of glycosphingolipids and expression of glycogenes in mouse brains.
Ngamukote S; Yanagisawa M; Ariga T; Ando S; Yu RK
J Neurochem; 2007 Dec; 103(6):2327-41. PubMed ID: 17883393
[TBL] [Abstract][Full Text] [Related]
10. Glycosphingolipid expression in solid tumours and transformed cell lines.
Berra B; Colombo I; Monteggia E; Montorfano G; Moretti S; Rapelli S; Sottocornola E
Indian J Biochem Biophys; 1997; 34(1-2):170-7. PubMed ID: 9343946
[TBL] [Abstract][Full Text] [Related]
11. Metabolic pathways and intracellular trafficking of gangliosides.
Daniotti JL; Iglesias-Bartolomé R
IUBMB Life; 2011 Jul; 63(7):513-20. PubMed ID: 21698755
[TBL] [Abstract][Full Text] [Related]
12. Cancer vaccines: an update with special focus on ganglioside antigens.
Bitton RJ; Guthmann MD; Gabri MR; Carnero AJ; Alonso DF; Fainboim L; Gomez DE
Oncol Rep; 2002; 9(2):267-76. PubMed ID: 11836591
[TBL] [Abstract][Full Text] [Related]
13.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
14.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
